David Lieberman, MD, PhD, provides an overview of Rett Syndrome, explores the patient perspective of Rett Syndrome, and discusses methods clinicians and payers use to evaluate treatment successes.
EP. 6: Clinical Trials Examining Rett Syndrome
December 13th 2022David Lieberman, MD, PhD, discusses the results of the phase 3 LAVENDER trial of trofinetide and the phase 3 AVATAR trial of blarcamesine and how patients and families can learn about eligible clinical trials for possible participation.
Watch
EP. 16: Resources and Programs Designed to Alleviate Burdens Associated with Rett Syndrome
January 31st 2023Paige Nues of the International Rett Syndrome Foundation discusses the complexity of navigating available resources and programs for patients with Rett syndrome, and the critical role of centers of excellence.
Watch